The historical rank and industry rank for Soiken Holdings's Days Payable or its related term are showing as below:
TSE:2385'
s Days Payable Range Over the Past 10 Years
Min: 24.65 Med: 30.39 Max: 47.61
Current: 47.61
During the past 13 years, Soiken Holdings's highest Days Payable was 47.61. The lowest was 24.65. And the median was 30.39.
TSE:2385's Days Payable is ranked worse than 69.37% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs TSE:2385: 47.61
Soiken Holdings's Days Payable
declined
from Jun. 2024 (22.80) to Dec. 2025 (0.00).
It may suggest that Soiken Holdingsaccelerated paying its suppliers.
Soiken Holdings Days Payable Related Terms
Soiken Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Soiken Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2385 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Soiken Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Soiken Holdings Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Soiken Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Soiken Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Soiken Holdings's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Soiken Holdings (TSE:2385) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Soiken Holdings and its competitors. Over the past decade, Soiken Holdings' Days Payable has ranged from 24.65 to 47.61. According to the industry distribution chart, Soiken Holdings ranks #487 out of 702 companies in the Biotechnology industry, placing it in the top 69.4%.
Is Soiken Holdings' Days Payable too high?
Soiken Holdings' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 24.65 to a high of 47.61. Based on the distribution chart, Soiken Holdings ranks #487 out of 702 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Soiken Holdings has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soiken Holdings' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Soiken Holdings ranks #487 out of 702 companies for Days Payable. This places Soiken Holdings in the lower half of its industry. The industry median Days Payable is 113.10. Historically, Soiken Holdings' own Days Payable has ranged from 24.65 to 47.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Soiken Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Soiken Holdings's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soiken Holdings stock overvalued right now?
Based on GuruFocus' analysis, Soiken Holdings (TSE:2385) is currently considered Significantly Overvalued. The stock's GF Value™ is 円114.55, compared to a current price of 円209.00 — trading 82.5% above its estimated fair value. The current Days Payable is 0.00. Soiken Holdings' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Soiken Holdings (TSE:2385), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Soiken Holdings (TSE:2385) Overvalued in 2026?
Based on GuruFocus' analysis, Soiken Holdings stock appears to be overvalued.
The current stock price of 円209.00 is trading 82.5% above its estimated GF Value™ of 円114.55.
GuruFocus considers Soiken Holdings to be Significantly Overvalued.
Key valuation signals for TSE:2385:
Days Payable: 0.00
GF Value™: 円114.55 vs. price of 円209.00 (82.5% above fair value)
No single metric tells the full story. See the TSE:2385 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.
56GF Score
Get the complete analysis for TSE:2385
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2385 has been successfully added to your 
